Syndrome  >>  hydrocortisone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrocortisone / Generic mfg.
NCT00003436: Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia

Completed
3
2000
Europe
amsacrine, asparaginase, cytarabine, daunorubicin hydrochloride, etoposide, methotrexate, mitoxantrone hydrochloride, therapeutic hydrocortisone, allogeneic bone marrow transplantation
Medical Research Council
Leukemia, Myelodysplastic Syndromes
 
12/05
NCT00002798: Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Completed
3
880
US
asparaginase, ASNase, Colaspase, Crasnitin, Elspar, L-ASP, daunorubicin hydrochloride, Cerubidin, Cerubidine, daunomycin hydrochloride, daunorubicin, RP-13057, fludarabine phosphate, 2-F-ara-AMP, Beneflur, Fludara, therapeutic hydrocortisone, Aeroseb-HC, Barseb HC, Cetacort, Cort-Dome, Cortef, allogeneic bone marrow transplantation, bone marrow therapy, allogeneic, bone marrow therapy, allogenic, transplantation, allogeneic bone marrow, transplantation, allogenic bone marrow, 3-dimensional conformal radiation therapy, 3D conformal radiation therapy, 3D-CRT, filgrastim, G-CSF, Neupogen, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, idarubicin, 4-demethoxydaunorubicin, 4-DMDR, DMDR, IDA, dexamethasone, Aeroseb-Dex, Decaderm, Decadron, DM, DXM, thioguanine, 6-TG, etoposide, EPEG, VP-16, VP-16-213, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, aldesleukin, IL-2, Proleukin, recombinant human interleukin-2, recombinant interleukin-2, busulfan, BSF, BU, Misulfan, Mitosan, Myeloleukon
National Cancer Institute (NCI)
Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Childhood Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, Refractory Anemia With Ringed Sideroblasts, Secondary Myelodysplastic Syndromes, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
09/06
 
COIITSS, NCT00320099: Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock

Completed
3
508
Europe
recombinant human insulin, hydrocortisone, fludrocortisone, Hydrocortisone
University of Versailles, Assistance Publique - Hôpitaux de Paris
Septic Shock
01/09
02/09
CORTIFLU, NCT01014364: Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu

Terminated
3
40
Europe
hydrocortisone, hydrocortisone acetate, isotonic saline, normal saline
University of Versailles, Assistance Publique - Hôpitaux de Paris
Pneumonia, Viral, Influenza in Humans
06/11
12/11
NCT02114710: Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock

Completed
3
240
RoW
Hydrocortisone
Nanjing PLA General Hospital
Coagulation Dysfunction in Septic Shock, Hemodynamic Improvement Induced by Hydrocortisone
10/12
10/12
HYPRESS, NCT00670254 / 2007-004401-10: Hydrocortisone for Prevention of Septic Shock

Completed
3
380
Europe
Placebo, Hydrocortisone
Charite University, Berlin, Germany, German Federal Ministry of Education and Research, SepNet - Critical Care Trials Group, Coordination Centre for Clinical Trials Leipzig
Severe Sepsis
08/13
08/13
NCT02266589: Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock

Completed
3
84
RoW
Hydrocortisone
Nanjing PLA General Hospital
Septic Shock, Sepsis
10/13
10/13
APROCCHS, NCT00625209 / 2007-004485-40: Activated Protein C and Corticosteroids for Human Septic Shock

Completed
3
1241
Europe
placebos, hydrocortisone and fludrocortisone and placebo, recombinant human activated protein C and placebos, recombinant human activated protein C and hydrocortisone and fludrocortisone
University of Versailles, Assistance Publique - Hôpitaux de Paris, Ministry of Health, France
Septic Shock
06/15
07/16

Download Options